Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2754342rdf:typepubmed:Citationlld:pubmed
pubmed-article:2754342lifeskim:mentionsumls-concept:C0237401lld:lifeskim
pubmed-article:2754342lifeskim:mentionsumls-concept:C0237868lld:lifeskim
pubmed-article:2754342lifeskim:mentionsumls-concept:C0017978lld:lifeskim
pubmed-article:2754342lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:2754342lifeskim:mentionsumls-concept:C0036679lld:lifeskim
pubmed-article:2754342lifeskim:mentionsumls-concept:C1705920lld:lifeskim
pubmed-article:2754342lifeskim:mentionsumls-concept:C0008562lld:lifeskim
pubmed-article:2754342pubmed:issue4lld:pubmed
pubmed-article:2754342pubmed:dateCreated1989-8-30lld:pubmed
pubmed-article:2754342pubmed:abstractTextThe high performance liquid chromatography separation of the perbenzoyl derivatives of the neutral glycosphingolipids (GlcCer, LacCer, GbOse3Cer, GbOse4Cer, and GgOse3Cer) and the p-bromophenacyl and 2,4-dinitrophenyl hydrazide derivatives of the gangliosides (GM4, GM3, GM2, GM1, GD1a) into individual molecular species on a C18 reversed-phase column is described. Peaks were identified by comparing their relative retention times to the relative retention time of the corresponding glycosphingolipid of known molecular species composition. As little as 5 to 10 pmol of each molecular species of neutral glycosphingolipids and 3 to 5 pmol of the gangliosides can be detected. The effects of changes in the proportion of acetonitrile, methanol, and water in the mobile phase and of column temperature on the molecular species separation are described. A procedure for the tentative identification of glycosphingolipid molecular species based on their relative retention times is presented.lld:pubmed
pubmed-article:2754342pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2754342pubmed:languageenglld:pubmed
pubmed-article:2754342pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2754342pubmed:citationSubsetIMlld:pubmed
pubmed-article:2754342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2754342pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2754342pubmed:statusMEDLINElld:pubmed
pubmed-article:2754342pubmed:monthAprlld:pubmed
pubmed-article:2754342pubmed:issn0022-2275lld:pubmed
pubmed-article:2754342pubmed:authorpubmed-author:KadowakiHHlld:pubmed
pubmed-article:2754342pubmed:authorpubmed-author:KoffR SRSlld:pubmed
pubmed-article:2754342pubmed:authorpubmed-author:Rys-SikoraK...lld:pubmed
pubmed-article:2754342pubmed:issnTypePrintlld:pubmed
pubmed-article:2754342pubmed:volume30lld:pubmed
pubmed-article:2754342pubmed:ownerNLMlld:pubmed
pubmed-article:2754342pubmed:authorsCompleteYlld:pubmed
pubmed-article:2754342pubmed:pagination616-27lld:pubmed
pubmed-article:2754342pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2754342pubmed:meshHeadingpubmed-meshheading:2754342-...lld:pubmed
pubmed-article:2754342pubmed:meshHeadingpubmed-meshheading:2754342-...lld:pubmed
pubmed-article:2754342pubmed:meshHeadingpubmed-meshheading:2754342-...lld:pubmed
pubmed-article:2754342pubmed:meshHeadingpubmed-meshheading:2754342-...lld:pubmed
pubmed-article:2754342pubmed:year1989lld:pubmed
pubmed-article:2754342pubmed:articleTitleSeparation of derivatized glycosphingolipids into individual molecular species by high performance liquid chromatography.lld:pubmed
pubmed-article:2754342pubmed:affiliationDepartment of Medicine, Framingham Union Hospital, MA 01701.lld:pubmed
pubmed-article:2754342pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2754342pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed